Chemical Compound

Doxazosin Mesilate Imp. H (EP); Prazosin Hydrochloride Imp. E (EP); Prazosin Imp. E (EP); Terazosin Hydrochloride Dihydrate Imp. E (EP); Terazosin Imp. E (EP); Terazosin USP Related Compound C; Terazosin USP RC C; 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine); 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine; Terazosin Related Compound C; Doxazosin Mesilate Impurity H; Prazosin Hydrochloride Impurity E; Terazosin Hydrochloride Dihydrate Impurity E; Doxazosin Impurity H; Prazosin Impurity E; Terazosin Impurity E

CAS Registry Number 102839-00-9
Doxazosin Mesilate Imp. H (EP); Prazosin Hydrochloride Imp. E (EP); Prazosin Imp. E (EP); Terazosin Hydrochloride Dihydrate Imp. E (EP); Terazosin Imp. E (EP); Terazosin USP Related Compound C; Terazosin USP RC C; 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine); 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine; Terazosin Related Compound C; Doxazosin Mesilate Impurity H; Prazosin Hydrochloride Impurity E; Terazosin Hydrochloride Dihydrate Impurity E; Doxazosin Impurity H; Prazosin Impurity E; Terazosin Impurity E 结构式
Primary record

Doxazosin Mesilate Imp. H (EP); Prazosin Hydrochloride Imp. E (EP); Prazosin Imp. E (EP); Terazosin Hydrochloride Dihydrate Imp. E (EP); Terazosin Imp. E (EP); Terazosin USP Related Compound C; Terazosin USP RC C; 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine); 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine; Terazosin Related Compound C; Doxazosin Mesilate Impurity H; Prazosin Hydrochloride Impurity E; Terazosin Hydrochloride Dihydrate Impurity E; Doxazosin Impurity H; Prazosin Impurity E; Terazosin Impurity E

库存
5,569 克
纯度
99.6 %
CAS
102839-00-9

化合物标识与属性

CAS
102839-00-9
PubChem CID
616293
SMILES
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC)N)OC
Canonical SMILES
COc1cc2nc(N3CCN(c4nc(N)c5cc(OC)c(OC)cc5n4)CC3)nc(N)c2cc1OC

名称与同义词

  • Doxazosin impurity H
  • 102839-00-9
  • Terazosin EP Impurity E
  • Terazosin impurity E
  • UNII-GZ7F9EWD85
  • AC1LDCYD
  • (Terazosin Impurity)"
  • GZ7F9EWD85
  • Terazosin dimer impurity
  • Prazosin EP Impurity E
  • RefChem:73128
  • Terazosin impurity E CRS
  • Oprea1_697601
  • Doxazosin mesilate impurity H
  • Doxazosin mesilate impurity H [EP]
  • DTXSID50145536
  • TCMDC-123865
  • GNF-Pf-3195
  • AMY192
  • CHEMBL546591
  • 1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine
  • 2,2'-(Piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
  • DTXCID5068027
  • SCHEMBL31187488
  • TCMDC 123865
  • XJWKWPCORQUMQI-UHFFFAOYSA-N
  • 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
  • C24H28N8O4
  • ZINC721858
  • CID616293
  • MFCD00844357
  • STK768256
  • Terazosin EP Impurity E (free base)
  • AKOS001734181
  • IP27062
  • ST039259
  • TERAZOSIN RELATED COMPOUND C FREE BASE
  • 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
  • FT-0673924
  • DOXAZOSIN MESILATE IMPURITY H [EP IMPURITY]
  • 4-Quinazolinamine, 2,2'-(1,4-piperazinediyl)bis(6,7-dimethoxy-
  • C10988
  • PRAZOSIN HYDROCHLORIDE IMPURITY E [EP IMPURITY]
  • A898857
  • SR-01000538610
  • A2800/0118358
  • DOXAZOSIN MESILATE IMPURITY H (EP IMPURITY)
  • SR-01000538610-1
  • PRAZOSIN HYDROCHLORIDE IMPURITY E (EP IMPURITY)
  • Q27279368
  • 2,2/'-(1,4-Piperazinediyl)bis[6,7-diMethoxy-4-quinazolinaMine]
  • TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY E [EP IMPURITY]
  • 1,4-Bis-(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine
  • 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine](Terazosin Impurity)
  • B2694-121537
  • 2,2'-piperazine-1,4-diylbis(6,7-dimethoxyquinazolin-4-amine)
  • 2,2''-(1,4-Piperazinediyl)Bis[6,7-Dimethoxy-4-Quinazolinamine]
  • 2,2'-(Piperazin-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
  • TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY E (EP IMPURITY)
  • 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
  • Prazosin EP Impurity E; Doxazosin EP Impurity H; Terazosin EP Impurity E
  • 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine] (Terazosin Impurity)
  • 2,2'-(1,4-Piperazinediyl)bis6,7-dimethoxy-4-quinazolinamine(Terazosin Impurity)
  • 2-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-6,7-dimethoxy-4-quinazolinylamine #
  • 2-[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-6,7-dimethoxy-quinazolin-4-amine
  • 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl]-6,7-dimethoxyquinazoli ne-4-ylamine
  • Doxazosin Mesilate Imp. H (EP); Prazosin Hydrochloride Imp. E (EP); Prazosin Imp. E (EP); Terazosin Hydrochloride Dihydrate Imp. E (EP); Terazosin Imp. E (EP); Terazosin USP Related Compound C; Terazosin USP RC C; 2,2'-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine); 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine; Terazosin Related Compound C; Doxazosin Mesilate Impurity H; Prazosin Hydrochloride Impurity E; Terazosin Hydrochloride Dihydrate Impurity E; Doxazosin Impurity H; Prazosin Impurity E; Terazosin Impurity E
  • Prazosin BP Impurity E; Terazosin EP Impurity E; 2,2?-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]